NJBIZ http://www.njbiz.com%2Fapps%2Fpbcs.dll%2Fsection%3FCategory%3D"> All Stories en-us http://www.njbiz.com/article/20130514/NJBIZ01/130519913&source=RSS Mylan marks 25th anniversary of landmark EpiPen Mylan Specialty has begun offering EpiPen, the landmark autoinjector that treats severe allegoric reactions, with no co-pay to mark the 25th anniversary of the product&#8217s approval by the Food and Drug Administration. Tue, 14 May 2013 13:50:00 EST http://www.njbiz.com/article/20130514/NJBIZ01/130519913&source=RSS http://www.njbiz.com/article/20130513/NJBIZ01/305109993&source=RSS Better diagnosis will save lives, boost company profit Cancer Genetics CEO Panna Sharma pins his hopes on the conviction that better diagnosis of cancer will extend lives and save money. It follows that investors would reward such diagnostics companies, he said. Fri, 10 May 2013 10:55:00 EST http://www.njbiz.com/article/20130513/NJBIZ01/305109993&source=RSS http://www.njbiz.com/article/20130510/NJBIZ01/130519987&source=RSS Senesco announced 1.25 million equity financing Senesco Technologies Inc. , of Bridgewater, announced Thursday it has entered into a securities purchase agreement with institutional investors to raise 1. 25 million in gross proceeds through the sale of 41. 8 million shares of its common stock, priced at 3 cents per share. Fri, 10 May 2013 09:35:00 EST http://www.njbiz.com/article/20130510/NJBIZ01/130519987&source=RSS http://www.njbiz.com/article/20130510/NJBIZ01/130519989&source=RSS Pharma, testing companies announce partnership Arno Therapeutics Inc. , a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced it has signed an agreement with Clarient Diagnostic Services Inc. , a GE Healthcare subsidiary, to develop a diagnostic test to identify activated progesterone receptors in endometrial cancer. Fri, 10 May 2013 09:32:00 EST http://www.njbiz.com/article/20130510/NJBIZ01/130519989&source=RSS http://www.njbiz.com/article/20130506/NJBIZ01/130509880&source=RSS For Quantex, new home is a new opportunity Quantex Laboratories believes it has found the right solution in Cranbury, moving into headquarters about triple the size of its prior Edison Township home that was badly damaged by Hurricane Sandy. Mon, 06 May 2013 12:53:00 EST http://www.njbiz.com/article/20130506/NJBIZ01/130509880&source=RSS http://www.njbiz.com/article/20130501/NJBIZ01/130509974&source=RSS Merck announces plan for 15 billion stock buyback Merck Co. announced a 15 billion stock buyback today, half of which the Hunterdon County pharmaceutical giant expects to purchase over the next 12 months. Wed, 01 May 2013 13:26:00 EST http://www.njbiz.com/article/20130501/NJBIZ01/130509974&source=RSS http://www.njbiz.com/article/20130501/NJBIZ01/130509983&source=RSS Celator completes 39.3 million private-placement financing Celator Pharmaceuticals Inc. , a clinical-stage biopharmaceutical company in Princeton developing new therapies to treat cancer, on Tuesday announced it has raised 32. 5 million in the final closing of a private placement of common stock and warrants to purchase common stock. Wed, 01 May 2013 09:46:00 EST http://www.njbiz.com/article/20130501/NJBIZ01/130509983&source=RSS http://www.njbiz.com/article/20130430/NJBIZ01/130439960&source=RSS At panel, speaker says emerging markets will power pharma growth Pharmaceutical industry growth depends heavily on emerging markets abroad, a health care expert told gatherers today at Rutgers Business School, in Newark. Tue, 30 Apr 2013 12:16:00 EST http://www.njbiz.com/article/20130430/NJBIZ01/130439960&source=RSS http://www.njbiz.com/article/20130430/NJBIZ01/130439978&source=RSS Biosciences firm announces plan to launch IPO Regado Biosciences Inc. , in the Basking Ridge section of Bernards, on Monday announced it has filed a registration statement with the U. S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock. Tue, 30 Apr 2013 09:24:00 EST http://www.njbiz.com/article/20130430/NJBIZ01/130439978&source=RSS http://www.njbiz.com/article/20130430/NJBIZ01/130439980&source=RSS Pfizer, Merck agree to collaborate on diabetes drug candidate Merck Co. , in the Whitehouse Station section of Readington, and New York-based Pfizer Inc. on Monday announced an agreement to develop and commercialize Pfizer&#8217s Ertugliflozin, an investigational drug being evaluated for the treatment of Type 2 diabetes. Tue, 30 Apr 2013 09:22:00 EST http://www.njbiz.com/article/20130430/NJBIZ01/130439980&source=RSS http://www.njbiz.com/article/20130430/NJBIZ01/130439981&source=RSS Jury finds Merck drug did not cause femur fracture Merck Co. , in the Whitehouse Station section of Readington, on Monday said a jury found in its favor in a suit in which the plaintiff claimed she used Fosamax and subsequently suffered an atypical femur fracture. Tue, 30 Apr 2013 09:21:00 EST http://www.njbiz.com/article/20130430/NJBIZ01/130439981&source=RSS http://www.njbiz.com/article/20130429/NJBIZ01/130429819&source=RSS NeoStem subsidiary announces agreement with Sentien Biotechnologies NeoStem Inc. , of Allendale, and its subsidiary, Progenitor Cell Therapy LLC, announced today the execution of a services agreement with SentienBiotechnologies Inc. Mon, 29 Apr 2013 09:25:00 EST http://www.njbiz.com/article/20130429/NJBIZ01/130429819&source=RSS http://www.njbiz.com/article/20130429/NJBIZ01/130429820&source=RSS Emisphere, Novo Nordisk amend drug development agreement Emisphere Technologies Inc. , of Roseland, today announced it has agreed with Novo Nordisk AS to amend the two companies' development and license agreement to develop and commercialize a drug candidate, to treat Type 2 diabetes, that uses Emisphere's Eligen technology. Mon, 29 Apr 2013 09:23:00 EST http://www.njbiz.com/article/20130429/NJBIZ01/130429820&source=RSS http://www.njbiz.com/article/20130429/NJBIZ01/130429822&source=RSS Bayer announces 1.1B merger with Conceptus Wayne-based Bayer HealthCare LLC announced today it will acquire Conceptus Inc. , the Mountain View, Calif. -based developer of the Essure procedure, as it broadens its portfolio in contraception. Mon, 29 Apr 2013 09:20:00 EST http://www.njbiz.com/article/20130429/NJBIZ01/130429822&source=RSS http://www.njbiz.com/article/20130425/NJBIZ01/130429883&source=RSS Advance Realty acquires Sanofi site in Bridgewater Advance Realty and a Boston-based investment partner have acquired the former Sanofi U. S. research and development complex in Bridgewater, where the Bedminster-based developer will soon relocate its headquarters, the companies announced today. Thu, 25 Apr 2013 12:30:00 EST http://www.njbiz.com/article/20130425/NJBIZ01/130429883&source=RSS